NanoPass Technologies Expands Product Portfolio to Advance Intradermal Deliverymonimono2026-01-18T11:31:00+00:00January 18th, 2026|Read More
MicronJet™ Continues Its Journey to Become the Gold Standard in Intradermal Deliverymonimono2025-12-31T09:51:30+00:00December 31st, 2025|Read More
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Devicemonimono2024-08-08T10:08:50+00:00August 4th, 2024|Read More
NanoPass Technologies Secures Awz Ventures’ $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technologymonimono2024-08-08T10:09:17+00:00July 15th, 2024|Read More
NanoPass’s intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biologymonimono2022-02-07T14:48:09+00:00February 7th, 2022|Read More
NanoPass’s intradermal delivery platform used in Emergex’s next generation COVID-19 vaccination studymonimono2022-01-26T15:45:55+00:00January 26th, 2022|Read More
NanoPass and M2N enter strategic development & foundry agreementmonimono2021-12-23T07:16:15+00:00December 22nd, 2021|Read More
NanoPass and AMP launch MicronJet®600 for aesthetics in the USAmonimono2021-12-19T13:55:21+00:00November 23rd, 2021|Read More
NanoPass Is Joining Forces with Pharma Partners in The Fight Against The COVID-19 Pandemicmonimono2021-01-26T09:29:54+00:00April 20th, 2020|Read More
